Indrayani Biotech Ltd Stock Price Today (NSE: INDRANIB)
Fundamental Score
Indrayani Biotech Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Indrayani Biotech Ltd share price today is ₹7.23, down 2.77% on NSE/BSE as of 30 March 2026. Indrayani Biotech Ltd (INDRANIB) is a Small-cap company in the Other Agricultural Products sector with a market capitalisation of ₹68.07 (Cr). The 52-week high for INDRANIB share price is ₹20.40 and the 52-week low is ₹6.10. The company has a Return on Equity (ROE) of -8.75% and a debt-to-equity ratio of 1.89.
Indrayani Biotech Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Indrayani Biotech Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Financial Analysis of Indrayani Biotech Share Price: A Fundamental Audit Perspective
The agricultural sector focusing on other agricultural products often benefits from specialized solutions that cater to niche markets and local farming needs. In this context, we examine the Indrayani Biotech share price, currently at ₹8.22, as part of a comprehensive 80-parameter fundamental audit verified by Sweta Mishra. This analysis aims to provide an objective assessment of the company's financial standing based on available data and publicly accessible information.
A key metric to consider is the Return on Capital Employed (ROCE). Indrayani Biotech Ltd presents a concerning ROCE of -1.12%. A negative ROCE suggests the company is not efficiently generating profits from its capital investments. This directly impacts the company's economic moat, weakening its ability to sustain competitive advantages and potentially hindering future growth prospects. Unlike companies with robust ROCE figures, Indrayani Biotech’s negative value indicates operational inefficiencies that require careful scrutiny.
When considering peer performance, comparing Indrayani Biotech with companies like
Kaveri Seed Company Limited highlights potential disparities in management quality and operational effectiveness. While this analysis doesn't offer an exhaustive evaluation of management, the stark difference in ROCE, assuming peers have positive figures, may reflect varying levels of managerial competency in capital allocation and strategic decision-making. It is crucial to assess not only the financials but also the qualitative aspects of the business to understand long-term sustainability. Publicly available information on Kaveri Seed Company Limited indicates higher management quality.The absence of a Price-to-Earnings (PE) ratio for Indrayani Biotech Ltd further complicates the analysis, potentially signaling a lack of profitability or insufficient earnings to calculate this key valuation metric. This lack of PE requires further investigation to determine the underlying causes and assess the company's earnings potential. This analysis relies solely on observable facts and financial ratios. This serves an informational purpose only and should not be construed as investment advice.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Indrayani Biotech Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of INDRANIB across key market metrics for learning purposes.
Positive Indicators
1 factors identified
Consistent Growth Track Record (21.21% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Risk Factors
9 factors identified
Below-Average Return on Equity (-8.75%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (-1.12%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Profit Decline Concern (-81.18%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-7.71%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Elevated Debt Levels (D/E: 1.89)
Observation: High leverage increases financial risk and interest burden.
Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.
Weak Interest Coverage (-3.07x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Negative Free Cash Flow (₹-52.50 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 3.13%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Indrayani Biotech Ltd Financial Statements
Comprehensive financial data for Indrayani Biotech Ltd including income statement, balance sheet and cash flow
About INDRANIB (Indrayani Biotech Ltd)
Indrayani Biotech Ltd is a pioneering force in the realm of agricultural innovation, focusing on the development and distribution of specialized products designed to enhance crop y...ields and promote sustainable farming practices. With a commitment to harnessing the power of biotechnology, the company cultivates solutions tailored to address the evolving needs of modern agriculture. Their core focus lies in creating advanced bio-stimulants, organic fertilizers, and specialized soil amendments, all rigorously tested and formulated to optimize plant health, improve nutrient uptake, and enhance resistance to environmental stresses. Indrayani Biotech strives to empower farmers with the tools necessary to cultivate thriving, resilient crops while minimizing the environmental impact of agricultural practices. The company's product portfolio extends beyond conventional agricultural inputs, encompassing a range of cutting-edge solutions for crop protection and enhancement. Indrayani Biotech is dedicated to developing and manufacturing innovative bio-pesticides and bio-fungicides, providing effective and environmentally responsible alternatives to traditional chemical treatments. These products are designed to target specific pests and diseases while preserving beneficial insect populations and minimizing the risk of soil contamination. Furthermore, the company invests in research and development to explore new avenues for improving crop resilience, including the development of drought-tolerant varieties and bio-fortified crops that offer enhanced nutritional value. Indrayani Biotech operates with a deep-seated commitment to sustainability and ethical sourcing, ensuring that its products are manufactured with minimal environmental impact and that its practices align with the principles of responsible agriculture. The company actively collaborates with farmers and agricultural experts to develop customized solutions tailored to specific regional needs and environmental conditions. Through comprehensive training programs and educational initiatives, Indrayani Biotech empowers farmers with the knowledge and resources necessary to implement sustainable farming practices and maximize the benefits of its innovative products. With a vision for a healthier, more sustainable future, Indrayani Biotech is dedicated to transforming the agricultural landscape through the power of biotechnology.
Company Details
Key Leadership
INDRANIB Share Price: Frequently Asked Questions
What is the current share price of Indrayani Biotech Ltd (INDRANIB)?
As of 30 Mar 2026, 12:03 pm IST, Indrayani Biotech Ltd share price is ₹7.23. The INDRANIB stock has a market capitalisation of ₹68.07 (Cr) on NSE/BSE.
Is INDRANIB share price Overvalued or Undervalued?
INDRANIB share price is currently trading at a P/E ratio of 0.00x, compared to the industry average of 21.07x. Based on this relative valuation, the Indrayani Biotech Ltd stock appears to be Fairly Valued against its sector peers.
What is the 52-week high and low of INDRANIB share price?
The 52-week high of INDRANIB share price is ₹20.40 and the 52-week low is ₹6.10. These values are updated daily from NSE/BSE price data.
What factors affect the Indrayani Biotech Ltd share price?
Key factors influencing INDRANIB share price include quarterly earnings growth (Sales Growth: -7.71%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Indrayani Biotech Ltd a good stock for long-term investment?
Indrayani Biotech Ltd shows a 5-year Profit Growth of N/A% and an ROE of -8.75%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 1.89 before investing in INDRANIB shares.
How does Indrayani Biotech Ltd compare with its industry peers?
Indrayani Biotech Ltd competes with major peers in the Other Agricultural Products. Investors should compare INDRANIB share price P/E of 0.00x and ROE of -8.75% against the industry averages to determine competitive standing.
What is the P/E ratio of INDRANIB and what does it mean?
INDRANIB share price has a P/E ratio of N/Ax compared to the industry average of 21.07x. Investors pay ₹N/A for every ₹1 of annual earnings.
How is INDRANIB performing according to Bull Run's analysis?
INDRANIB has a Bull Run fundamental score of 2.6/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does INDRANIB belong to?
INDRANIB operates in the Other Agricultural Products industry. This classification helps understand the competitive landscape and sector-specific trends affecting Indrayani Biotech Ltd share price.
What is Return on Equity (ROE) and why is it important for INDRANIB?
INDRANIB has an ROE of -8.75%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Indrayani Biotech Ltd generates profits from shareholders capital.
How is INDRANIB debt-to-equity ratio and what does it indicate?
INDRANIB has a debt-to-equity ratio of 1.89, which indicates high leverage that increases financial risk.
What is INDRANIB dividend yield and is it a good dividend stock?
INDRANIB offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Indrayani Biotech Ltd shares.
How has INDRANIB share price grown over the past 5 years?
INDRANIB has achieved 5-year growth rates of: Sales Growth 21.21%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in INDRANIB and why does it matter?
Promoters hold 33.26% of INDRANIB shares, with 2.46% pledged. High promoter holding often indicates strong management confidence in Indrayani Biotech Ltd.
What is INDRANIB market capitalisation category?
INDRANIB has a market capitalisation of ₹68 crores, placing it in the Small-cap category.
How volatile is INDRANIB stock?
INDRANIB has a beta of N/A. A beta > 1 suggests the Indrayani Biotech Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is INDRANIB operating profit margin trend?
INDRANIB has a 5-year average Operating Profit Margin (OPM) of 10.74%, indicating the company's operational efficiency.
How is INDRANIB quarterly performance?
Recent quarterly performance shows Indrayani Biotech Ltd YoY Sales Growth of -7.71% and YoY Profit Growth of -81.18%.
What is the institutional holding pattern in INDRANIB?
INDRANIB has FII holding of 0.00% and DII holding of 3.13%. Significant institutional holding often suggests professional confidence in the Indrayani Biotech Ltd stock.